Estracombi TTS

Country: New Zealand

Language: English

Source: Medsafe (Medicines Safety Authority)

Active ingredient:

Estradiol 4mg (releases 50 µg/24 hours);  ; Estradiol 10mg (releases 50 µg/24 hours); Norethisterone acetate 30mg (releases 0.25 mg/24 hours);  

Available from:

Novartis New Zealand Ltd

INN (International Name):

Estradiol 4 mg (releases 50 µg/24 hours)

Pharmaceutical form:

Transdermal patch

Composition:

Active: Estradiol 4mg (releases 50 µg/24 hours)   Excipient: Ethanol Hyprolose Active: Estradiol 10mg (releases 50 µg/24 hours) Norethisterone acetate 30mg (releases 0.25 mg/24 hours)   Excipient: Ethanol Hyprolose

Units in package:

Combination pack, 4 Estraderm + 4 Estragest, 8 patches

Class:

Prescription

Prescription type:

Prescription

Manufactured by:

NV Organon

Product summary:

Package - Contents - Shelf Life: Combination pack, 4 Estraderm + 4 Estragest - 8 patches - 24 months from date of manufacture stored at or below 25°C - Sachet, laminate, Estragest TTS 0.25/50 - 1 patches - 24 months from date of manufacture stored at or below 25°C - Sachet, laminate, Estraderm TTS 50 - 1 patches - 24 months from date of manufacture stored at or below 25°C

Authorization date:

1991-04-09